Literature DB >> 1895885

Oxysterol incorporation into rat aorta resulting in elastin compositional changes.

J W Blankenship1, C M Van Gent, L B Sandberg, P J Roos, J A Scharffenberg.   

Abstract

The incorporation of dietary cholestan-3 beta,5 alpha,6 beta-triol (triol) into rat thoracic aortic tissue and changes in amino acid composition of the elastin were investigated to identify the cytotoxic properties of the triol. Weanling male Sprague-Dawley rats were fed the following diets for three months: (i) normal chow, (ii) normal chow with 1% (w/w) cholesterol added, or (iii) normal chow with 0.9% (w/w) cholesterol and 0.1% (w/w) triol added. Triol levels in the blood and in the thoracic aortic tissue were measured. Compositional changes of elastin were also determined. After three months on the triol-containing diet, triol was found in the thoracic aorta but was not detected in the blood. Amino acid analyses of the aortic tissue elastin revealed that the proline levels in the triol-fed animals were significantly greater than in the other two diet groups, while the elastin levels of leucine, aspartate, arginine, and phenylalanine decreased significantly. The mechanism for these observed changes induced by triol may reflect alternate splicing of elastin messenger ribonucleic acid (mRNA) resulting in structual changes in the elastin molecule. Dietary triol does contribute to tissue triol content and is associated with aortic elastin compositional changes. How these changes may contribute to the development of cardiovascular disease is not known.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895885     DOI: 10.1007/bf02537203

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  Quantitation of elastin through measurement of its pentapeptide content.

Authors:  L B Sandberg; T B Wolt; J G Leslie
Journal:  Biochem Biophys Res Commun       Date:  1986-04-29       Impact factor: 3.575

2.  A new acid hydrolysis method for determining tryptophan in peptides and proteins.

Authors:  B Penke; R Ferenczi; K Kovács
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

3.  Experimental atherosclerosis in rabbits after feeding cholestanetriol.

Authors:  R P Cook; J D MacDougall
Journal:  Br J Exp Pathol       Date:  1968-06

4.  Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis.

Authors:  S K Peng; P Tham; C B Taylor; B Mikkelson
Journal:  Am J Clin Nutr       Date:  1979-05       Impact factor: 7.045

5.  Connective tissue responses to oxysterols.

Authors:  A Baranowski; C W Adams; O B High; D B Bowyer
Journal:  Atherosclerosis       Date:  1982-02       Impact factor: 5.162

6.  Effect of auto-oxidation products from cholesterol on aortic smooth muscle cells: an in vitro study.

Authors:  S K Peng; C B Taylor; P Tham; N T Werthessen; B Mikkelson
Journal:  Arch Pathol Lab Med       Date:  1978-02       Impact factor: 5.534

7.  Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations.

Authors:  M S Jacobson
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

8.  Cholesterol oxidation derivatives and arterial endothelial damage.

Authors:  S K Peng; C B Taylor; J C Hill; R J Morin
Journal:  Atherosclerosis       Date:  1985-02       Impact factor: 5.162

9.  Quantification of oxysterols in Dutch foods: egg products and mixed diets.

Authors:  P van de Bovenkamp; T G Kosmeijer-Schuil; M B Katan
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

10.  Influence of cholesterol oxidation derivatives on membrane bound enzymes in cultured aortic smooth muscle cells.

Authors:  S K Peng; J C Hill; R J Morin; C B Taylor
Journal:  Proc Soc Exp Biol Med       Date:  1985-10
View more
  1 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.